Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men

Clinical Pharmacology and Therapeutics

Volumn 71, Issue 3, 2002, Pages 162-168

  Jürgens, Gesche ^a,b,c,d   Lange, Kai Henrik Wiborg ^a,b,c,d   Reuther, Lene Ørskov ^a,b,c,d   Rasmussen, Birgitte Buur ^a,b,c,d   Brøsen, Kim ^a,b,c,d   Christensen, Hanne Rolighed ^a,b,c,d  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; HUMAN GROWTH HORMONE; HYDROCORTISONE; MEPHENYTOIN; PHENAZONE; PLACEBO; SPARTEINE;

ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG METABOLISM; DYSESTHESIA; EDEMA; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; MALE; METABOLIC RATE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRINE; CYTOCHROME P-450 ENZYME SYSTEM; DOUBLE-BLIND METHOD; GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE;

EID: 0036218060     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2002.121373     Document Type: Article

References (29)

1. Physiological and pathophysiological regulation of cytochrome P450
2. Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man
3. 2 breath test
4. Effect of human growth hormone on amobarbital metabolism in children
5. Effect of growth hormone on human drug metabolism: Time course and substrate specificity
6. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes
7. Assessment of liver metabolic function: Clinical implications
8. Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation
9. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine
10. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans
11. Recent advances: The cytochrome P450 enzymes
12. Drug metabolism by cytochromes P450 in the liver and small bowel
13. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index
14. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency
15. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation
16. Theophylline has no advantages over caffeine as a putative model drug for assessing CYP1A2 activity in humans
17. A urinary metabolite ratio that reflects systemic caffeine clearance
18. Sparteine metabolism in Canadian Caucasians
19. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine
20. Age and severe adverse drug reactions caused by nifedipine and verapamil
21. The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction
22. Antipyrine clearance in pneumonia
23. A simple method for determination of antipyrine clearance
24. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects
25. Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity
26. Gender differences in the responsiveness of the sex-dependent isoforms of hepatic P450 to the feminine plasma growth hormone profile
27. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine
28. Caffeine as a metabolic probe: Validation of its use for acetylator phenotyping
29. Cigarette smoking and theophylline clearance and metabolism